TGF-β signaling has a central role in the cancer progression of PDAC because (i) the TGF-β pathway naturally contains mutations and other well-defined alterations; and (ii) it belongs to only four signaling pathways that are mutated (with at least one gene) in 100% of tumors [5]. This evidence concerns the gene TGFB1 and cancer.